Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Patients older than 18 years, both genders, without any previous treatment with statins or other lipid lowering drugs for at least 6 months

• With elevated triglycerides above 200 and below 800mg/dl and willing to follow all study procedures including assisting to clinics, fasting before blood samples and signing a written consent

Exclusion Criteria:

• High levels of low-density lipoprotein cholesterol (LDL-C)

• Unstable cardiovascular condition or awaiting a myocardial revascularization

• Congestive cardiac failure

• Uncontrolled diabetes

• Cancer

• Uncontrolled hypothyroidism

• Familial hypercholesterolemia

• Liver/muscle disease

• Pregnancy

• Other